Yan JL - Search Results

1

Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h.

Cheng K, Pypstra R, Yan JL, Hammond J. Cheng K, et al. Among authors: yan jl. J Antimicrob Chemother. 2019 Apr 1;74(4):1086-1091. doi: 10.1093/jac/dky519. J Antimicrob Chemother. 2019. PMID: 30597021 Free PMC article. Clinical Trial.

2

Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study.

Purdy J, Jouve S, Yan JL, Balter I, Dartois N, Cooper CA, Korth-Bradley J. Purdy J, et al. Among authors: yan jl. Clin Ther. 2012 Feb;34(2):496-507.e1. doi: 10.1016/j.clinthera.2011.12.010. Epub 2012 Jan 16. Clin Ther. 2012. PMID: 22249106 Clinical Trial.

3

Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.

Ramirez J, Dartois N, Gandjini H, Yan JL, Korth-Bradley J, McGovern PC. Ramirez J, et al. Among authors: yan jl. Antimicrob Agents Chemother. 2013 Apr;57(4):1756-62. doi: 10.1128/AAC.01232-12. Epub 2013 Jan 28. Antimicrob Agents Chemother. 2013. PMID: 23357775 Free PMC article. Clinical Trial.

4

Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.

Bassetti M, McGovern PC, Wenisch C, Meyer RD, Yan JL, Wible M, Rottinghaus ST, Quintana A. Bassetti M, et al. Among authors: yan jl. Int J Antimicrob Agents. 2015 Sep;46(3):346-50. doi: 10.1016/j.ijantimicag.2015.05.012. Epub 2015 Jun 25. Int J Antimicrob Agents. 2015. PMID: 26155003 Free article.

5

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.

Kullberg BJ, Vasquez J, Mootsikapun P, Nucci M, Paiva JA, Garbino J, Yan JL, Aram J, Capparella MR, Conte U, Schlamm H, Swanson R, Herbrecht R. Kullberg BJ, et al. Among authors: yan jl. J Antimicrob Chemother. 2017 Aug 1;72(8):2368-2377. doi: 10.1093/jac/dkx116. J Antimicrob Chemother. 2017. PMID: 28459966 Free PMC article.

6

Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.

Das S, Li J, Iaconis J, Zhou D, Stone GG, Yan JL, Melnick D. Das S, et al. Among authors: yan jl. J Antimicrob Chemother. 2019 Feb 1;74(2):425-431. doi: 10.1093/jac/dky439. J Antimicrob Chemother. 2019. PMID: 30380060 Free PMC article.

7

Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis.

Bradley JS, Stone GG, Chan PLS, Raber SR, Riccobene T, Mas Casullo V, Yan JL, Hendrick VM, Hammond J, Leister-Tebbe HK. Bradley JS, et al. Among authors: yan jl. Pediatr Infect Dis J. 2020 May;39(5):411-418. doi: 10.1097/INF.0000000000002607. Pediatr Infect Dis J. 2020. PMID: 32091493 Clinical Trial.

8

Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam.

Sánchez-García M, Hammond J, Yan JL, Kantecki M, Ansari W, Dryden M. Sánchez-García M, et al. Among authors: yan jl. Infect Dis Ther. 2020 Sep;9(3):609-623. doi: 10.1007/s40121-020-00297-3. Epub 2020 Jun 30. Infect Dis Ther. 2020. PMID: 32607967 Free PMC article.

9

Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.

Dryden M, Kantecki M, Yan JL, Stone GG, Leister-Tebbe H, Wilcox M. Dryden M, et al. Among authors: yan jl. J Glob Antimicrob Resist. 2022 Mar;28:108-114. doi: 10.1016/j.jgar.2021.10.027. Epub 2021 Dec 16. J Glob Antimicrob Resist. 2022. PMID: 34922058 Free article.

10

Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies.

Sganga G, Wang M, Capparella MR, Tawadrous M, Yan JL, Aram JA, Montravers P. Sganga G, et al. Among authors: yan jl. Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1849-1856. doi: 10.1007/s10096-019-03617-9. Epub 2019 Jul 6. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31280481 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters